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Aims: To evaluate the effect of limb preservation status and body mass index (BMI) on the survival of patients
with diabetic foot ulcers (DFUs).
Methods: A total of 1346 patients treated for limb-threatening DFUs at a major diabetic foot center in Taiwan
from 2002 to 2009 were tracked until December 2012. The patients were classiﬁed into three groups:
limb-preserved (n = 858), minor lower-extremity amputation (LEA) (n = 249), and major LEA (n = 239).
Clinical data during treatment were used for survival analysis.
Results:With 729 deaths, themedian survival time (MST) was 6.14 (95% CI 5.63–6.65) years. Major LEA and BMI
were two independent factors associated with mortality after adjusting for age, diabetic duration, HbA1c level,
comorbidities and peripheral artery diseases. The mortality hazard ratios for the minor and major LEA groups
were 0.92 (95% CI 0.74–1.16) and 1.34 (95% CI 1.07–1.68), respectively, to the reference group (limb-preserved).
After stratifying BMI into four categories (underweight, normal weight, overweight and obesity, according to the
Taiwanese deﬁnition), the MSTs for each category were 2.57, 5.24, 7.47 and 7.85 years, respectively (P for trend
b0.01). This “obesity paradox”was not observed in themajor LEA group (P for trend 0.25). For patientswith LEA,
the obesity patients had lowerMST than those in overweight category (7.97 and 8.84 inminor and 3.25 and 5.42
in major LEA, respectively).
Conclusions: For the patients treated for DFUs, major – but not minor – LEA was associated with poor survival
compared with the limb-preserved group. The MST had positive correlation with BMI levels for patients with
limb-preserved and minor LEA, but not for those with major LEA.
© 201 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
7    1. Introduction
Recent studies have reported poor long-term outcomes for patients
with diabetic foot ulcers (DFUs) (Iversen et al., 2009;Moulik,Mtonga, &
Gill, 2003), with a 5-year survival rate of around 55% (Morbach et al.,
2012; Moulik et al., 2003). Although factors such as age (Morbach et al.,
2012; Tseng et al., 2008), renal function (Lavery et al., 2010; Morbach
et al., 2012), and co-existing peripheral artery disease (Morbach et al.,
2012) have been reported to be associatedwithmortality, the impact ofand Metabolism, Chang Gung
City 333, Taiwan. Tel.: +886 3
Inc. This is an open access article ufactors such as limb preservation status and bodymass index (BMI) has
not been fully elucidated.
A higher mortality rate has been reported in diabetic subjects with
major lower-extremity amputation (LEA) (above the ankle) thanminor
LEA (below the ankle) (Hambleton et al., 2009; Izumi, Satterﬁeld, Lee,
Harkless, & Lavery, 2009). The current study is an investigation of the
long-term risk of mortality for patients with limb-threatening DFUs,
with speciﬁc analysis of limb status after in-hospital treatment.
Obesity is a known risk factor associated with diabetes mellitus
(Colditz,Willett, Rotnitzky, &Manson, 1995), hypertension (Huang et al.,
1998), cardiovascular disease (Kim, Owen,Williams, & Adams-Campbell,
2000) and death (Adams et al., 2006; Flegal, Graubard, Williamson, &
Gail, 2005). Nevertheless, the so-called “obesity paradox”, which
suggests obese people have a greater chance of survival than people
with normal weight, has recently been reported for certain chronic
diseases (Lavie, De Schutter, & Milani, 2015). These included chronicnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stroke (Andersen & Olsen, 2015), hemodialysis (Kalantar-Zadeh et al.,
2012), diabetes (Carnethon et al., 2012), and peripheral artery disease
(Kumakura et al., 2010). BMI may also play a role in the survival of
patients with DFUs, although this has yet to be veriﬁed.
The aim of this studywas to investigate the survival and associated
risk factors for mortality of patients with limb-threatening DFUs. Limb
preservation status after treatment and BMI level were the two main
factors of interest in this study.
2. Patients and methods
2.1. Patients and hospital care
In this study, we retrospectively analyzed the medical chart notes of
patientswith type 2 diabetes admitted to ChangGungMemorial Hospital
(a 3700-bed teaching and referring hospital) for limb-threatening foot
ulcers at our Diabetic Foot Center between January 2002 and December
2009. A limb-threatening foot ulcer is deﬁned as an ulcer accompanied
with limb-threatening infection (Frykberg et al., 2006) or critical limb
ischemia (Norgren et al., 2007). The limb-threatening infection was
prescribed if at least one of the following conditionswas present: greater
than 2 cm of cellulitis around an ulcer, lymphangitis, soft tissue necrosis,
gangrene, and osteomyelitis (Frykberg et al., 2006). This foot center was
certiﬁed by the International Diabetes Federation-West Paciﬁc Region.
The institutional review board of Chang Gung Memorial Hospital
approved this study (no. 104-1401B).
All patients were admitted for comprehensive foot care by a
multidisciplinary team. This team included diabetologists, cardiologists,
and vascular, plastic, and orthopedic surgeons. The patients received
prompt empiric systemic antibiotic treatment, wound debridement and
dressing. Surgical interventions such as debridement, drainage, digital
or foot amputation or revascularization were scheduled after the
investigative diabetic team reached a consensus (Hung et al., 2015; Sun
et al., 2012).
A total of 1346 type 2 diabetic patients were identiﬁed who
completed treatment for limb-threatening DFUs. All were discharged
with a clean ulcer or healedwound (surgical debridement or amputated
wound included)which could bemanaged at home. Themean duration
of hospitalization was 30.62 ± 23.65 days.
2.2. Data collection
Survival timewas calculated from thedischarge date toDecember 31,
2012, or death. Causes and the date of death were obtained from the
National Death Registry of the Taiwan National Health Insurance
Database and classiﬁed in accordance with the ninth revision of the
International Classiﬁcation ofDiseases (Huang et al., 2012; Li et al., 2012).
Demographic informationwas recorded from thepatients'ﬁrst visit at
admission and used for survival analysis. Limb preservation status at
discharge was stratiﬁed into three groups: limb-preserved (i.e., no
amputationperformed,n = 858),minor LEA (i.e., amputationperformed
including digital amputation or tarsal-metatarsal amputation, as long as it
did not involve the ankle area, n = 249), andmajor LEA (i.e., amputation
performed above the ankle joint,n = 239). Themedical records included
the patient's age, gender, diabetes duration, body weight/height, HbA1c
level and medical history such as hypertension, history of major adverse
cardiac events (MACEs; including coronary artery disease and cerebro-
vascular accidents) and dialysis. BMI was determined on the ﬁrst day of
admission and calculated as the weight in kilograms divided by the
square of the height in meters (kg/m2). Smokers were classiﬁed as
currently smoking if they smoked at least one cigarette per day. The
estimated glomerular ﬁltration rate (eGFR) was calculated using the
Modiﬁcation of Diet in Renal Disease Study equation: 175 × serum
creatinine (exp[−1.154]) × age (exp[0.203]) × (0.742 if female). Renal
status was categorized as follows: normal or mild chronic kidneydisease (eGFR ≥60 ml/min); moderate to severe chronic kidney disease
(eGFR b60 ml/min); and dialysis according to the National Kidney
Disease Outcomes Quality Initiative (NKDOQI) guidelines. Ankle brachial
index (ABI) was obtained by measuring blood pressure at the ankle and
in the armwhile the patient was at rest. Peripheral artery disease (PAD)
was deﬁned as either an abnormal ABI (≤ 0.9 or N1.4 according to the
2011 American Heart Association guidelines) or evidence of arterial
occlusion by CT angiography or Doppler waveform (Rooke et al., 2011;
Tsai et al., 2013).
2.3. Statistics
Age, duration of diabetes, BMI and HbA1c level were used as
continuous variables, and gender, smoking status, and co-morbidities
were used as categorical variables. Comparisons between the three limb
preservation groups were performed using one-way ANOVA for
continuous variables and Pearson's chi-square test for categorical
variables. The ability of each variable to predict mortality (hazard ratio)
was calculated using univariate Cox regression analysis. The signiﬁcant
risk factors in the univariate analysis were then entered into a
multivariate Cox regression model with adjustments for covariates to
identify independent risk factors. The information for those individuals
who were alive at the end of the study was collected as right-censored
data and the Kaplan–Meier method was therefore used to calculate the
median survival time (MST). All statistical analyseswere performedusing
the Statistical Package for the Social Sciences (SPSS forWindows, version
19.0, Armonk, NY: IBM Corp.) data analysis software.
3. Results
3.1. Demographic data
Seven hundred twenty-nine of the 1346 patients died during the
study period. The 5-year survival ratewas 57%with aMST of 6.14 (95%CI
5.63–6.65) years and a crude mortality rate of 114.5 per 1000
patient-years. The observation period of this study was up to 10 years
(median: 4.33 years, range: 0.03–10.47). The demographic and clinical
data of the studypopulation are presented inTable 1. Themeanageof the
patients was 63.84 ± 12.51 years, and 55.5% of them were male. The
mean BMI was 24.53 ± 4.24 kg/m2, which is considered to be
overweight according to the Taiwanese deﬁnition (underweight:
b18.5, normal weight: 18.5–23.9, overweight: 24–26.9, and obesity:
≥27 kg/m2) (Hwang, Bai, &Chen, 2006). Sixtypercent of the subjects had
underlying hypertension, 24% had MACEs, and 12% were undergoing
chronic dialysis for end-stage renal disease. Thirty-three percent of the
patients (n = 440) had PAD, of whom 71 (16%) received revasculariza-
tion interventions (62 endovascular treatment and 9 bypass grafting).
The patients with major LEA tended to be older (mean
66.08 years) with a lower BMI (mean 23.56 kg/m2), more underlying
co-morbidities (72% hypertension, 35% MACEs, 27% dialysis), and to
have PAD (49%) when compared with the limb-preserved group or
the minor LEA group.
3.2. Survival analysis
All variables listed in Table 1 except for gender and smoking status
were entered into the multivariate Cox regression model. Age, chronic
kidney disease or dialysis, MACEs, PAD, major LEA and BMI were
independent risk factors associated with long-termmortality (Table 2).
The patients with PAD had a higher risk of mortality [adjusted HR 1.31
(95%CI 1.09–1.56)]. TheMSTs for thepatientswith PADwhodidanddid
not receive interventionswere3.74 and3.97 years, respectively, and the
difference did not reach statistical signiﬁcance (P value 0.69).
Of note, there was no increase in mortality between the limb-
preserved andminor LEAgroups (Table 2 and Fig. 1).When the datawere
compared with respect to the limb-preserved group, the adjusted
Table 1
Demographics and clinical characteristics of the patients with diabetic foot ulcers.
Characteristic Mean (standard deviation) or no. (%)
All patients
(n = 1346)
Limb-preserved
(n = 858)
Minor LEA
(n = 249)
Major LEA
(n = 239)
P value
Mortality no. 729 426 130 173
MST (95% CI) (years) 6.14 (5.63–6.65) 7.09 (6.42–7.76) 6.96 (5.67–8.25) 3.25 (2.23–4.27)
5-year survival probability 57% 61% 60% 39%
Age (years) 63.84 (±12.51) 63.51 (±12.84) 62.84 (±12.30) 66.08 (±11.27) b0.01
Male gender 747 (56%) 467 (54%) 146 (59%) 134 (56%) 0.49
Diabetes duration (years) 11.48 (±8.08) 10.88 (±7.88) 11.52 (±8.39) 13.58 (±8.15) b0.01
Body mass index 24.53 (±4.24) 24.91 (±4.44) 24.18 (±3.62) 23.56 (±3.92) b0.01
Smoker 256 (19%) 164 (19%) 52 (21%) 40 (17%) 0.50
Hypertension 812 (60%) 495 (58%) 144 (58%) 173 (72%) b0.01
Major adverse cardiac eventa 323 (24%) 185 (22%) 54 (22%) 84 (35%) b0.01
Peripheral artery disease 440 (33%) 229 (27%) 94 (38%) 117 (49%) b0.01
Revascularizationc 71 (16%) 37 (16%) 21 (22%) 13 (11%) 0.09
Renal function
Normal renal function
(eGFR ≧60)
583 (43%) 407 (47%) 107 (43%) 69 (29%) b0.01
Chronic kidney disease
(eGFR b60)
602 (45%) 391 (46%) 105 (42%) 106 (44%) 0.63
Dialysis 161 (12%) 60 (7%) 37 (15%) 64 (27%) b0.01
HbA1c (%)b 9.21 (±2.49) 9.18 (±2.51) 9.67 (±2.49) 8.73 (±2.31) b0.01
MST = median survival time; eGFR = estimated glomerular ﬁltration rate; LEA = lower-extremity amputation.
a Major adverse cardiac events including history of ischemic heart disease or coronary artery disease, cerebral vascular accident with embolic, ischemic, or hemorrhagic stroke.
b Total available HbA1c data in 1043 subjects.
c Revascularization including angioplasty and open surgical revascularization.
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1.16) and 1.34 (95% CI 1.07–1.68), respectively (Table 2). There was a
negative correlationbetweenBMIandmortality [adjustedHR0.95 (95%CI
0.93–0.97)] (Table 2).Table 2
Mortality risk factor analysis using Cox proportional hazards analysis.
Characteristic Univariate analysis Multivariate+ analysis
Mortality HR
(95% CI)
P value Mortality HR
(95% CI)
P value
Age (years) 1.04⁎ (1.03–1.05) b0.01 1.03⁎ (1.03–1.04) b0.01
Gender
Male 1
Female 1.06 (0.91–1.22) 0.47
Diabetes duration (years) 1.03⁎ (1.03–1.04) b0.01 1.00 (0.99–1.01) 0.55
Body mass index 0.94⁎ (0.93–0.96) b0.01 0.95⁎ (0.93–0.97) b0.01
Smoker 0.95 (0.79–1.15) 0.61
Hypertension 1.54⁎ (1.32–1.79) b0.01 1.07 (0.88–1.31) 0.48
Major adverse cardiac event 1.95⁎ (1.67–2.28) b0.01 1.50⁎ (1.23–1.82) b0.01
Peripheral artery disease 2.00⁎ (1.72–2.32) b0.01 1.31⁎ (1.09–1.56) b0.01
Renal function
Normal renal function
(eGFR≧60)
1 1
Chronic kidney disease
(eGFR b60)
1.90⁎ (1.61–2.24) b0.01 1.44⁎ (1.18–1.77) b0.01
Dialysis 3.92⁎ (3.14–4.89) b0.01 3.04⁎ (2.25–4.11) b0.01
HbA1c (%) 0.92⁎ (0.88–0.95) b0.01 1.00 (0.96–1.04) 0.90
Limb preservation status
Limb-preserved 1 1
Minor LEA 1.09 (0.90–1.33) 0.38 0.92 (0.74–1.16) 0.49
Major LEA 1.88⁎ (1.58–2.25) b0.01 1.34⁎ (1.07–1.68) 0.01
LEA = lower-extremity amputation.
⁎ Signiﬁcance: P value b0.05.
+ Including continuous variables of age, diabetes duration, body mass index, and
HbA1c; and categorical variables of hypertension, major adverse cardiac events,
peripheral artery disease, renal function and limb preservation status.3.3. Survival analysis between limb preservation status and BMI categories
After stratifying BMI into four categories of BMI classiﬁcation
(Hwang et al., 2006), the MSTs were 2.57 (95% CI 1.94–3.2), 5.24 (95%
CI 4.66–5.82), 7.47 (95%CI 6.41–8.53) and7.85 (95%CI 6.57–9.13) years,
respectively, in the underweight, normal weight, overweight and
obesity groups, with a signiﬁcant increasing trend (P for trend b0.01)
(Table 3). When the data of the normal weight patients were used as
reference, the adjusted mortality hazard ratios for the underweight,
overweight, and obesity groupswere 1.77 (95% CI 1.25–2.51), 0.78 (95%
CI 0.63–0.96), and 0.68 (95% CI 0.54–0.86), respectively (Table 3).
Similar trends were observed in the limb-preserved and minor LEA
groups (Fig. 2), with both P values for trend b0.01 (Table 3), but not in
the major LEA group (P value 0.25). The longest MST for the minor and
major LEA groups was in the overweight patients (8.84 and 5.42 years,
respectively) (Fig. 2 and Table 3). The subjects with LEA in the obesity
group had a decrease in MST (8.84 to 7.97 years in minor and 5.42 to
3.25 years in major LEA).
3.4. Causes of death
The most common cause of mortality in the 729 subjects who died
was: documented cardiovascular disease (18.6% overall; coronary heart
disease 11.8%; cerebrovascular disease 6.7%; and peripheral vascular
disease 0.01%), followed by kidney complications (8.4%), infectious
diseases (8.4%), and malignancy (8%). Approximately 44% of those who
died had an uncertain diagnosis.
4. Discussion
In addition to age (Tseng et al., 2008), concurrent MACEs (Morbach
et al., 2012), chronic kidney disease (Lavery et al., 2010), and PAD
(Morbach et al., 2012), major LEA status and BMI were major factors
affecting survival in the patients with DFUs in this study. The 5-year
survival rate of the study population was 57%, which is similar to
previous studies (Morbach et al., 2012; Moulik et al., 2003).
Fig. 1. Adjusted survival curve via a Cox proportional hazard model separated by limb preservation status. Compared to the limb-preserved group, the adjusted mortality hazard
ratios were 0.92 (95% CI 0.74–1.16, P = 0.49) for minor LEA and 1.34 (95% CI 1.07–1.68, P = 0.01) for major LEA. Covariates included continuous variables of age, diabetes duration,
body mass index, and HbA1c; and categorical variables of hypertension, major adverse cardiac events, peripheral artery disease, and renal function.
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prognosis in patients with a higher LEA level (Hambleton et al., 2009;
Izumi et al., 2009; Lavery et al., 2010). Compared to the patients with
minor LEA in this study, thosewithmajor LEAhad a33% increased riskof
mortality, which is consistent with the hazard ratios reported in
previous studies (range 1.1–2.43) (Hambleton et al., 2009; Izumi et al.,
2009; Lavery et al., 2010; Tseng et al., 2008). Difﬁculty in ambulation
following LEAs may increase the risk of mortality. That is, limited
mobility (Davies & Datta, 2003), bed-ridden status (Inderbitzi,
Buettiker, & Enzler, 2003), and higher risk of falls (Pauley, Devlin, &
Heslin, 2006) may all contribute to poor survival. As a higher
amputation level may result in poor ambulation (Suckow et al., 2012),Table 3
Survival analysis between limb preservation status and category of BMI.
BMI No. Kaplan–Meier MST
(95% CI) (years)
Pa for trend
All Underweight 66 2.57 (1.94–3.20) b0.01
Normal 583 5.24 (4.66–5.82)
Overweight 372 7.47 (6.41–8.53)
Obesity 325 7.85 (6.57–9.13)
Limb-preserved Underweight 40 3.30 (1.22–5.38) b0.01
Normal 342 5.90 (4.96–6.85)
Overweight 236 7.11 (6.22–8.00)
Obesity 240 8.47 (7.00–9.94)
Minor LEA Underweight 9 2.10 (0.64–3.56) b0.01
Normal 118 5.07 (3.32–6.82)
Overweight 75 8.84 (NAb)
Obesity 47 7.97 (5.65–10.29)
Major LEA Underweight 17 2.24 (0.57–3.91) 0.25
Normal 123 3.21 (2.05–4.37)
Overweight 61 5.42 (2.86–7.98)
Obesity 38 3.25 (2.23–4.27)
BMI = body mass index; MST = median survival time; MHR = mortality hazard ratio; LE
⁎ Signiﬁcance: P value b0.05.
+ Including continuous variables of age, diabetes duration, and HbA1c; and categorical v
renal function.
a Log rank test for linear trend in Kaplan–Meier survival estimates.
b NA = not available, because nearly 50% survival probability.patients with major LEA have a poorer survival than those with minor
LEA. Furthermore, a major LEA itself may increase the risk of
cardiovascular disease because of behavioral changes, psychosocial
stress, and increases in inﬂammation and insulin resistance (Naschitz &
Lenger, 2008). Nevertheless, it is difﬁcult to determine the direction of
causality. In this study, thepatientswithmajor LEAhadmoreunderlying
diseases (Table 1). The underlying disease may have led to the DFU and
the amputation. Therefore, amputation may be involved in the
progression to death. For example, patients with major LEA had more
severe PAD, which is an indicator of more severe generalized
atherosclerosis resulting in a higher mortality rate (Leng et al., 1996).
Of note, this study is the ﬁrst to shownodifferences in survival betweenUnadjusted MHR (95% CI) P for HR Adjusted+ MHR (95% CI) P for HR
1.68⁎ (1.25–2.26) b0.01 1.77⁎ (1.25–2.50) b0.01
1 1
0.74⁎ (0.62–0.88) b0.01 0.78⁎ (0.63–0.96) 0.02
0.65⁎ (0.53–0.78) b0.01 0.68⁎ (0.54–0.86) b0.01
1.67 (1.12–2.48) 0.01 1.42 (0.87–2.32) 0.16
1 1
0.92 (0.73–1.16) 0.48 0.92 (0.71–1.21) 0.57
0.66⁎ (0.51–0.84) b0.01 0.63⁎ (0.46–0.85) b0.01
2.50⁎ (1.20–5.22) 0.01 3.22⁎ (1.39–7.47) b0.01
1 1
0.41⁎ (0.26–0.65) b0.01 0.43⁎ (0.25–0.75) b0.01
0.53⁎ (0.32–0.86) 0.01 0.59 (0.33–1.03) 0.06
1.42 (0.81–2.49) 0.22 1.69 (0.83–3.41) 0.15
1 1
0.67⁎ (0.45–0.99) 0.04 0.75 (0.45–1.24) 0.26
1.04 (0.69–1.57) 0.84 1.39 (0.79–2.44) 0.26
A = lower-extremity amputation.
ariables of hypertension, major adverse cardiac events, peripheral artery disease, and
Fig. 2. Median survival time of the patients with DFUs according to limb preservation status and BMI category. There was an increasing trend of median survival time with BMI
category in all patients and the limb-preserved and minor LEA groups, but not in the major LEA group. Underweight includes subjects with a BMI b18.5, normal weight BMI: 18.5–
23.9, overweight BMI: 24–26.9, and obesity BMI ≥27.
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DFUs. Sometimes sacriﬁcing part of a limb is inevitable when treating
patients with limb-threatening DFUs, such as in those with co-existing
severe infections or ischemia. Our results suggest that the level of LEA
should bekept to aminimumas far aspossible, as this not only improves
the quality of life but also leads to better long-term survival.
The relationship between BMI and mortality usually manifests as a
U-shape in bothWestern and Eastern populations, indicating the highest
mortality rates in patients who are either underweight or obese (Adams
et al., 2006; Chen et al., 2012; Flegal et al., 2005; Tamakoshi et al., 2010).
The phenomenon of obesity paradox suggests a better chance of survival
in obese subjects. Several hypotheseshavebeenpostulated to explain the
obesity paradox (Hainer & Aldhoon-Hainerova, 2013). Patients with a
higher BMI may be receiving optimal medication for hypertension or
hyperlipidemia (Schenkeveld et al., 2012), and they may have more
musclemass (Oreopoulos et al., 2010;Wannamethee, Shaper, Lennon, &
Whincup, 2007) or better nutritional status (Casas-Vara et al., 2012) and
hencemore strength to handle a severe illness. A higher BMImay also be
associated with decreased thromboxane production (Graziani et al.,
2011) or increased production of soluble tumor necrosis factor receptor
(Feldman et al., 2000), both of which may contribute to survival from
cardiovascular disease. To thebest of our knowledge, this study is theﬁrst
to provide evidence of the obesity paradox with regards to survival for
patients with DFUs.
Althoughahigher BMImeansbetter survival in this studypopulation,
differenceswere foundbetween the three groups of limb status based on
BMI categories. For patientswith LEA, the highestMSTwas found for the
overweight subjects. A lower MST for the patients with obesity was
observedmore prominent for the patientswithmajor LEA than for those
with minor LEA. Although it is difﬁcult to determine the direct etiology,
obesity is known to affect the musculoskeletal system, includingosteoarthritis, osteoporosis, low back pain, and gait disturbance
(Anandacoomarasamy, Caterson, Sambrook, Fransen, & March, 2008).
Therefore, it is possible that obesity in patientswith LEA further hampers
their mobility due to the burden on their musculoskeletal system. Such
immobilitymay then lead to organdysfunction including cardiovascular,
respiratory, musculoskeletal, and neuropsychological changes, and
ultimately mortality (Brown, Friedkin, & Inouye, 2004; Harper & Lyles,
1988; Siu et al., 2006). However, the causal relationship was difﬁcult to
identify in our study, and further studies are needed to verify our
hypothesis.
This study is limitedby the single center and retrospective design. The
limb-threateningDFUs of our patientsmaynot be generalized to patients
with chronic foot ulcers. In addition, data on mobility and ambulation
ability were not available in these patients after the critical foot event.
Moreover, certain clinical features such as waist circumference, body fat
and nutritional status were not available. The uncertain diagnosis in the
records of mortality from the registry database makes further analysis of
the causal relationship to mortality difﬁcult. Further studies may be
needed to verify the range of weight and muscle strength and physical
performance in patients with DFUs and different limb status.5. Conclusions
In summary, limb status at treatment and BMI were independent
factors for survival in patients with DFUs. Since major – but not minor –
LEA was associated with poor survival, aggressive treatment to reduce
the need for a major LEA may not only be beneﬁcial for limb
preservation, but also for the long-term prognosis. The median survival
time increased with increasing BMI for patients with limb-preserved
and minor LEA, but not for those with major LEA.
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